91Ó°ÊÓ

Refer to a landmark study conducted in 1896 in Denmark by Dr. Johannes Fibiger, who went on to receive the Nobel Prize in Medicine in \(1926 .\) The purpose of the study was to determine the effectiveness of a new serum for treating diphtheria, a common and often deadly respiratory disease in those days. Fibiger conducted his study over a one-year period (May 1896-April 1897) in one particular Copenhagen hospital. New diphtheria patients admitted to the hospital received different treatments based on the day of admission. In one set of days (call them "even" days for convenience), the patients were treated with the new serum daily and received the standard treatment. Patients admitted on alternate days (the "odd" days) received just the standard treatment. Over the one-year period of the study, eight of the 239 patients admitted on the "even" days and treated with the serum died, whereas 30 of the 245 patients admitted on the "odd" days died. (a) Describe the control and treatment groups in Fibiger's study. (b) What conclusions would you draw from Fibiger's study? Explain.

Step by step solution

01

Identify Control and Treatment Groups

The control group is the group of patients who were admitted on 'odd' days. These patients received only the standard treatment for diphtheria. The treatment group is the group of patients who were admitted on 'even' days. They were treated with the new serum alongside the standard treatment.

02

Analyze Death Rates and Draw Conclusions

Over the one-year period, 8 out of 239 patients in the treatment group died. This represents a mortality rate of \(\frac{8}{239} \approx 0.0335\), or about 3.35%. On the other hand, 30 out of the 245 patients in the control group died, a mortality rate of \(\frac{30}{245} \approx 0.1224\), or about 12.24%. From these statistics, it can be concluded that the new serum appears to have a significant effect in reducing the mortality rate of diphtheria, as the death rate is considerably lower in the treatment group than in the control group.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Experimental Design

Experimental design is a methodical approach to conducting scientific research. It aims to ascertain cause-and-effect relationships by controlling various variables. In the early days of research like Dr. Fibiger's 1896 study, setting up an experiment was key to drawing meaningful conclusions. An experiment typically involves dividing subjects into different groups, manipulating certain factors, and observing the outcomes. In Fibiger's study, he monitored the effectiveness of a diphtheria serum by creating a controlled environment within a single Copenhagen hospital. A well-structured experimental design ensures that variables other than the one being tested, in this case, the serum's effectiveness, do not affect the outcome. This methodical approach is what gives scientific research its robustness and validity.

Control Group

The control group acts as a baseline in experiments, providing a standard by which the effects of the treatment can be compared. In Fibiger's study, the patients who were admitted on 'odd' days and received only the standard treatment were the control group. It's crucial that the control group is similar to the treatment group in every way possible except for the treatment being tested. This similarity ensures that differences in outcomes can be attributed to the treatment itself rather than other factors. By contrasting the results between the control and treatment groups, researchers can isolate the effect of the new serum, validating whether the intervention has a significant impact.

Treatment Group

In an experimental design, the treatment group is subjected to the intervention being tested. For Fibiger's study, patients admitted on 'even' days made up the treatment group. They received the standard diphtheria treatment along with the new serum. By adding the serum to the existing treatment, researchers aimed to determine its additional benefits. Studies often have multiple treatment groups to test different variables or dosages, but Fibiger's study focused solely on comparing the serum's effect. This method allowed for a clear evaluation of its effectiveness, isolated from other changes.

Mortality Rate

The mortality rate is a vital statistic in medical studies that aids in understanding the impact of a treatment. It is essentially the proportion of deaths within a specific group over a set period. In the mentioned study, the treatment group's mortality rate was roughly 3.35%, while the control group had a significantly higher rate of about 12.24%. These numbers are more than just statistics; they reflect the potential life-saving capacity of the intervention being studied. Lower mortality rates in the treatment group suggest that the new serum may effectively reduce deaths from diphtheria.

Clinical Trial

A clinical trial is a research study performed with human subjects to evaluate medical interventions. Dr. Fibiger’s study is an early example of a clinical trial. These trials are crucial for determining the safety and efficacy of new treatments. They usually progress in stages, starting with small-scale tests and potentially escalating to larger populations if successful. The outcomes of a clinical trial can lead to groundbreaking advancements in medicine, as evident in this case, with substantial reductions in mortality rates serving as compelling evidence for the serum's benefits.